BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34309899)

  • 1. IRTA1 positivity helps identify a MALT-lymphoma-like subset of primary cutaneous marginal zone lymphomas, largely but not exclusively defined by IgM expression.
    Carlsen ED; Bhavsar S; Cook JR; Swerdlow SH
    J Cutan Pathol; 2022 Jan; 49(1):55-60. PubMed ID: 34309899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma.
    Ikeda JI; Kohara M; Tsuruta Y; Nojima S; Tahara S; Ohshima K; Kurashige M; Wada N; Morii E
    Hum Pathol; 2017 Jan; 59():70-79. PubMed ID: 27666766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry for IRTA1 and MNDA helps differentiate gastric MALT lymphoma from chronic gastritis/reactive lymphocyte hyperplasia.
    Ayada Y; Igawa T; Naoi Y; Horikawa K; Tabata T; Tanaka T; Yoshino T
    J Clin Exp Hematop; 2022 Dec; 62(4):195-201. PubMed ID: 36436933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How I Diagnose Primary Cutaneous Marginal Zone Lymphoma.
    Gibson SE; Swerdlow SH
    Am J Clin Pathol; 2020 Sep; 154(4):428-449. PubMed ID: 32808967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRTA1 and MNDA Expression in Marginal Zone Lymphoma: Utility in Differential Diagnosis and Implications for Classification.
    Wang Z; Cook JR
    Am J Clin Pathol; 2019 Feb; 151(3):337-343. PubMed ID: 30346478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Distinctive Nature of Thyroid MALT Lymphomas Including IRTA1 Expression.
    Carlsen ED; Davis AR; Cook JR; Swerdlow SH
    Am J Surg Pathol; 2023 Mar; 47(3):370-378. PubMed ID: 36729757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class-switched Primary Cutaneous Marginal Zone Lymphomas Are Frequently IgG4-positive and Have Features Distinct From IgM-positive Cases.
    Carlsen ED; Swerdlow SH; Cook JR; Gibson SE
    Am J Surg Pathol; 2019 Oct; 43(10):1403-1412. PubMed ID: 31464711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markers.
    Bob R; Falini B; Marafioti T; Paterson JC; Pileri S; Stein H
    Histopathology; 2013 Oct; 63(4):482-98. PubMed ID: 23855758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG4 Expression in Primary Cutaneous Marginal Zone Lymphoma: A Multicenter Study.
    De Souza A; Ferry JA; Burghart DR; Tinguely M; Goyal A; Duncan LM; Kutzner H; Kempf W
    Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):462-467. PubMed ID: 28151793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
    Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
    Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets.
    Edinger JT; Kant JA; Swerdlow SH
    Am J Surg Pathol; 2010 Dec; 34(12):1830-41. PubMed ID: 21107089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas.
    Falini B; Agostinelli C; Bigerna B; Pucciarini A; Pacini R; Tabarrini A; Falcinelli F; Piccioli M; Paulli M; Gambacorta M; Ponzoni M; Tiacci E; Ascani S; Martelli MP; Dalla Favera R; Stein H; Pileri SA
    Histopathology; 2012 Nov; 61(5):930-41. PubMed ID: 22716304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous marginal zone lymphomas.
    Swerdlow SH
    Semin Diagn Pathol; 2017 Jan; 34(1):76-84. PubMed ID: 27986434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT).
    Falini B; Tiacci E; Pucciarini A; Bigerna B; Kurth J; Hatzivassiliou G; Droetto S; Galletti BV; Gambacorta M; Orazi A; Pasqualucci L; Miller I; Kuppers R; Dalla-Favera R; Cattoretti G
    Blood; 2003 Nov; 102(10):3684-92. PubMed ID: 12881317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic features and expression of Bcl-2 and p53 proteins in primary gastric lymphomas.
    Dogusoy G; Karayel FA; Göcener S; Göksel S
    Pathol Oncol Res; 1999; 5(1):36-40. PubMed ID: 10079376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia.
    Goyal A; Moore JB; Gimbel D; Carter JB; Kroshinsky D; Ferry JA; Harris NL; Duncan LM
    J Cutan Pathol; 2015 Jan; 42(1):6-15. PubMed ID: 25384543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment.
    van Maldegem F; van Dijk R; Wormhoudt TA; Kluin PM; Willemze R; Cerroni L; van Noesel CJ; Bende RJ
    Blood; 2008 Oct; 112(8):3355-61. PubMed ID: 18687986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous marginal zone lymphoma with subclinical cutaneous involvement and biclonality.
    Edinger JT; Lorenzo CR; Breneman DL; Swerdlow SH
    J Cutan Pathol; 2011 Sep; 38(9):724-30. PubMed ID: 21623870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast MALT Lymphoma: A Clinical, Histomorphologic, and Immunophenotypic Evaluation.
    Yan M; Wang J; Gadde R; Bomeisl P; Gilmore H; Harbhajanka A
    Int J Surg Pathol; 2023 Oct; 31(7):1283-1293. PubMed ID: 36802856
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary cutaneous marginal zone lymphoma with sequential development of nodal marginal zone lymphoma in a patient with selective immunoglobulin A deficiency.
    Wobser M; Kerstan A; Kneitz H; Goebeler M; Kunzmann V; Rosenwald A; Geissinger E
    J Cutan Pathol; 2013 Dec; 40(12):1035-41. PubMed ID: 24274426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.